The 5 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 11.00, with a high estimate of 13.00 and a low estimate of 7.00. The median estimate represents a +305.16% increase from the last price of 2.72.
The current consensus among 5 polled investment analysts is to Buy stock in Mustang Bio Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.18
Reporting Date Nov 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.